|
1
|
Tummala MK and McGuire WP: Recurrent
ovarian cancer. Clin Adv Hematol Oncol. 3:723–736. 2005.PubMed/NCBI
|
|
2
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matsui W, Huff CA, Wang Q, Malehorn MT,
Barber J, Tanhehco Y, Smith BD, Civin CI and Jones RJ:
Characterization of clonogenic multiple myeloma cells. Blood.
103:2332–2336. 2004. View Article : Google Scholar
|
|
4
|
Taniguchi S, Imayoshi Y, Kobayashi E,
Takamatsu Y, Ito H, Hatano T, Sakagami H, Tokuda H, Nishino H,
Sugita D, et al: Production of bioactive triterpenes by Eriobotrya
japonica calli. Phytochemistry. 59:315–323. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsu YL, Kuo PL and Lin CC: Proliferative
inhibition, cell-cycle dysregulation, and induction of apoptosis by
ursolic acid in human non-small cell lung cancer A549 cells. Life
Sci. 75:2303–2316. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hollósy F, Idei M, Csorba G, Szabó E,
Bökönyi G, Seprödi A, Mészáros G, Szende B and Kéri G: Activation
of caspase-3 protease during the process of ursolic acid and its
derivative-induced apoptosis. Anticancer Res. 21:3485–3491.
2001.
|
|
7
|
Zhang YY, Deng T, Hu ZF, Zhang QP, Zhang J
and Jiang H: Mechanisms of inhibiting proliferation and inducing
apoptosis of human gastric cancer cell line SGC7901 by ursolic
acid. Ai Zheng. 25:432–437. 2006.In Chinese. PubMed/NCBI
|
|
8
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo X, Dong Z, Chen Y, Yang L and Lai D:
Enrichment of ovarian cancer stem-like cells is associated with
epithelial to mesenchymal transition through an miRNA-activated AKT
pathway. Cell Prolif. 46:436–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu P, Qiao J, He W, Wang J, Jia Y, Sun Y,
Tang S, Fu L and Qin Y: Genome-wide gene expression profile
analyses identify CTTN as a potential prognostic marker in
esophageal cancer. PLoS One. 9:e889182014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Galli R, Binda E, Orfanelli U, Cipelletti
B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi
A: Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Uchida N, Buck DW, He D, Reitsma MJ, Masek
M, Phan TV, Tsukamoto AS, Gage FH and Weissman IL: Direct isolation
of human central nervous system stem cells. Proc Natl Acad Sci USA.
97:14720–14725. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dontu G, Abdallah WM, Foley JM, Jackson
KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and
transcriptional profiling of human mammary stem/progenitor cells.
Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bapat SA, Mali AM, Koppikar CB and Kurrey
NK: Stem and progenitor-like cells contribute to the aggressive
behavior of human epithelial ovarian cancer. Cancer Res.
65:3025–3029. 2005.PubMed/NCBI
|
|
17
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F,
Maclaughlin DT and Donahoe PK: Ovarian cancer side population
defines cells with stem cell-like characteristics and Mullerian
Inhibiting Substance responsiveness. Proc Natl Acad Sci USA.
103:11154–11159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harmand PO, Duval R, Delage C and Simon A:
Ursolic acid induces apoptosis through mitochondrial intrinsic
pathway and caspase-3 activation in M4Beu melanoma cells. Int J
Cancer. 114:1–11. 2005. View Article : Google Scholar
|
|
19
|
Duval RE, Harmand PO, Jayat-Vignoles C,
Cook-Moreau J, Pinon A, Delage C and Simon A: Differential
involvement of mitochondria during ursolic acid-induced apoptotic
process in HaCaT and M4Beu cells. Oncol Rep. 19:145–149. 2008.
|
|
20
|
Kassi E, Sourlingas TG, Spiliotaki M,
Papoutsi Z, Pratsinis H, Aligiannis N and Moutsatsou P: Ursolic
acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast
cancer cells. Cancer Invest. 27:723–733. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang C, Lu YH, Xie JH, Wang F, Zou JN,
Yang JS, Xing YY and Xi T: Downregulation of survivin and
activation of caspase-3 through the PI3K/Akt pathway in ursolic
acid-induced HepG2 cell apoptosis. Anticancer Drugs. 20:249–258.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meng YQ, Liu D, Cai LL, Chen H, Cao B and
Wang YZ: The synthesis of ursolic acid derivatives with cytotoxic
activity and the investigation of their preliminary mechanism of
action. Bioorg Med Chem. 17:848–854. 2009. View Article : Google Scholar
|
|
23
|
Huang HC, Huang CY, Lin-Shiau SY and Lin
JK: Ursolic acid inhibits IL-1beta or TNF-alpha-induced C6 glioma
invasion through suppressing the association ZIP/p62 with PKC-zeta
and downregulating the MMP-9 expression. Mol Carcinog. 48:517–531.
2009. View
Article : Google Scholar
|
|
24
|
Molenaar JJ, Ebus ME, Koster J, van Sluis
P, van Noesel CJ, Versteeg R and Caron HN: Cyclin D1 and CDK4
activity contribute to the undifferentiated phenotype in
neuroblastoma. Cancer Res. 68:2599–2609. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takai M, Terai Y, Kawaguchi H, Ashihara K,
Fujiwara S, Tanaka T, Tsunetoh S, Tanaka Y, Sasaki H, Kanemura M,
et al: The EMT (epithelial-mesenchymal-transition) related protein
expression indicates the metastatic status and prognosis in
patients with ovarian cancer. J Ovarian Res. 27:7:762014.
View Article : Google Scholar
|
|
26
|
Tomaskovic-Crook E, Thompson EW and Thiery
JP: Epithelial to mesenchymal transition and breast cancer. Breast
Cancer Res. 11:2132009. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chiu WT, Huang YF, Tsai HY, Chen CC, Chang
CH, Huang SC, Hsu KF and Chou CY: FOXM1 confers to
epithelial-mesenchymal transition, stemness and chemoresistance in
epithelial ovarian carcinoma cells. Oncotarget. 6:2349–2365. 2015.
View Article : Google Scholar :
|
|
28
|
Shan JZ, Xuan YY, Ruan SQ and Sun M:
Proliferation-inhibiting and apoptosis-inducing effects of ursolic
acid and oleanolic acid on multi-drug resistance cancer cells in
vitro. Chin J Integr Med. 17:607–611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kyrgiou M, Salanti G, Pavlidis N,
Paraskevaidis E and Ioannidis JP: Survival benefits with diverse
chemotherapy regimens for ovarian cancer: Meta-analysis of multiple
treatments. J Natl Cancer Inst. 98:1655–1663. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Itamochi H: Targeted therapies in
epithelial ovarian cancer: Molecular mechanisms of action. World J
Biol Chem. 1:209–220. 2010. View Article : Google Scholar
|
